Navigation Links
Biogen Idec's baminercept alfa shows promise in patients with rheumatoid arthritis
Date:6/12/2008

Paris, France June 12, 2008 -- Biogen Idec will present data on baminercept alfa (BG9924, LTR-Ig), the first dual-mechanism, lymphotoxin-; (LT-;) and LIGHT pathway inhibitor in development for the treatment of autoimmune diseases, including rheumatoid arthritis (RA), during the 2008 European League Against Rheumatism (EULAR) Annual European Congress of Rheumatology at the Le Palais de Congrs de Paris. Three abstracts will be presented, including one podium presentation highlighting the Phase IIa preliminary safety and efficacy data as well as two poster presentations. The Phase IIa data suggest baminercept alfa is well tolerated. DAS, EULAR and other efficacy measures were improved in patients receiving baminercept alfa vs. patients receiving placebo and persisted up to eight weeks after the final baminercept alfa injection.

Podium presentation

  • "Preliminary safety and efficacy of Baminercept alfa (BG9924, LTR-Ig) in the treatment of rheumatoid arthritis" (Presentation OP-0122 Thursday, June 12, 13:30 CEST, Ternes Session Room)

Poster presentations

  • "Long-term safety assessment of Baminercept alfa (BG9924, LTR-Ig) in Cynomolgus monkeys (Poster FRI0156 Friday, June 13, 11:45 13:30 CEST)
  • "Treatment of cynomolgus monkeys with Baminercept alfa (BG9924, LTR-Ig) results in modulation of a specialized vasculature implicated in lymphocyte trafficking to areas of chronic inflammation" (Poster SAT0040 Saturday, June 14, 10:15 12:00 CEST)

"We are excited to take part in the Annual European Congress of Rheumatology and to share promising results for baminercept alfa," said Ajay Nirula, Director of Medical Research at Biogen Idec. "We are committed to developing new treatment options for those living with RA and are encouraged that results from the Phase IIa study suggest that innovative targeting of a new pathway may be effective in treating this disease."

Phase IIa D
'/>"/>

Contact: Rachi Govil
rachi.govil@offspringpr.com
212-798-9827
Offspring PR
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Broad Stakeholder Coalition Concludes that the Pathway for Biosimilars Act Fails to Ensure Timely Access to Safe, Affordable Biogeneric Medicines for Patients
2. New MedPAC Report: Abbreviated Biogenerics Pathway Urgently Needed
3. PCMA 2008 Agenda: Support E-Prescribing, Biogenerics; Oppose Bills that Increase Costs
4. Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
5. New Bird Flu Vaccine Shows Promise
6. New research shows room for improvement in health news
7. Opting out revolution a myth: Study shows steep employment gains for women, mothers
8. New KLRI Reports Shows Longevity Science Moving Beyond Studying the Obvious to the Downward Spiral Paradigm in the Aging Process
9. New Treatment Shows Promise for Excessive Drinking
10. New Heart Ultrasound Research Shows Hope for Diagnosing and Treating Fatal Heart Conditions
11. Blood Cancer Drug Shows Promise Against Lupus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... Nwe is the co-author of a new weight loss book ... the Ace Medical Weight Loss Center in Rock Hill, SC. ... the industry of weight loss, and how several fad diets ... television shows, however, she says the topic of obesity is ... basic laughs, which she believes impacts whether Americans view it ...
(Date:12/17/2014)... December 17, 2014 In its comprehensive ... and its Argus Claim Review division have recently identified ... most common ways savings are achieved on behalf of ... millions of dollars in savings to Argus each year, ... , As explained by Tom Doney, Cypress president and ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... one worrisome phenomenon is when an illness that originated in ... as zoonosis -- is not uncommon and keeps researchers on ... disease might make inroads into the human population. A ... the culprits in this case were guinea pigs. More specifically, ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... improve overall health, but a growing body of evidence shows ... review finds. In fact, the benefits were similar to ... researcher Paula Chu, a doctoral candidate at Harvard University,s Health ... trials, found that people randomly assigned to take yoga classes ...
(Date:12/15/2014)... Main Street Dental Team ( http://www.MainStreetDentalTeam.com ), ... a new study providing evidence on the impact of ... children. , Sufficient enough evidence already exists showing a ... juice drinks, with the onset of tooth decay. One ... listed as 100% fruit juice, meaning it is completely ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2
... that one in five men in their 40s has ... year and that young black men are more likely than ... published in the September 15, 2008 issue of CANCER ... valuable information as experts discuss possible changes to prostate cancer ...
... chemical might lead to drug treatments for humans , , SUNDAY, ... of mice resistant to diet-induced obesity. , The findings ... in people. They also shed light on the brain circuitry ... energy (i.e., food) an animal takes in and how quickly ...
... leading provider of enterprise portal connectivity solutions, announced ... Health Centre and Dr. Jay Wallin of Mount ... the monthly educational series reThinking eHealth. The session, ... physicians share ways their facilities have improved provider ...
... second shot now recommended , , FRIDAY, Aug. 8 (HealthDay News) ... United States in 1995, medical experts hoped it would be ... of a child,s first birthday giving lifelong immunity. , Now, ... protection from a single immunization fades over time, and that ...
... of Miley Cyrus and,the Jonas Brothers will have more ... artists take the stage with other performers at Disney,s,Concert ... programs at City of Hope. It will be held ... Tickets for the concert will,be available Saturday, August 16 ...
... TORONTO, Aug. 8 /PRNewswire/ - IntelliPharmaCeutics is pleased ... this press release to,the Company, include IntelliPharmaCeutics Ltd. ... has been very active with drug development work ... in Toronto, Canada. We,presently have 34 staff employed ...
Cached Medicine News:Health News:1 in 5 young men has had recent prostate cancer test 2Health News:Scientists Create Mice Resistant to Obesity 2Health News:Scientists Create Mice Resistant to Obesity 3Health News:Give the Providers What They Want: Two Physicians Share Ways Their Facilities Have Improved Provider Satisfaction 2Health News:Give the Providers What They Want: Two Physicians Share Ways Their Facilities Have Improved Provider Satisfaction 3Health News:Give the Providers What They Want: Two Physicians Share Ways Their Facilities Have Improved Provider Satisfaction 4Health News:Chickenpox Protection: Get That Booster 2Health News:Chickenpox Protection: Get That Booster 3Health News:The Walt Disney Company Is Presenting Miley Cyrus, Jonas Brothers and Demi Lovato in a Special Concert to Benefit City of Hope on September 14 2Health News:The Walt Disney Company Is Presenting Miley Cyrus, Jonas Brothers and Demi Lovato in a Special Concert to Benefit City of Hope on September 14 3Health News:IntelliPharmaCeutics Provides Update on Activities 2Health News:IntelliPharmaCeutics Provides Update on Activities 3Health News:IntelliPharmaCeutics Provides Update on Activities 4
(Date:12/15/2014)... , December 15, 2014 Investor-Edge has ... ZGNX ), Eli Lilly and Company (NYSE: ... (NYSE: SNY ), and Novartis AG (NYSE: ... be accessed at: http://investor-edge.com/register . On Friday, ... 1.16%, the Dow Jones Industrial Average lost 1.79%, to finish ...
(Date:12/15/2014)... Dec. 15, 2014  Stephen Squires, CEO and founder ... Materials Corp (OTCQB:QTMM), will be speaking at the ... (RCQM) on December 16th, 2014. The RCQM launch continues ... in attracting top faculty and students and by inviting ... research. "We have a long association ...
(Date:12/15/2014)...  The Government of Ghana has endorsed ... (GBF) and Terumo BCT to respond to the emerging Ebola crisis ... long-term health system capacity to the citizens of Ghana ... Ebola Readiness and Resilience Initiative (GERRI) is a multi-agency effort designed ... the possible arrival of the Ebola epidemic , Provide new ...
Breaking Medicine Technology:Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 2Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 3Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 4Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 5Government of Ghana Endorses Collaboration to Combat Ebola Epidemic 6
... 14, 2010 VIVUS, Inc. (Nasdaq: VVUS ) ... effort to secure regulatory approval for QNEXA® in the U.S., ... (FDA) designed to address items in the FDA,s Complete Response ... announced that the Endocrine and Metabolic Division of the FDA ...
... Science, Inc. (OTC Bulletin Board: CBIS ) a ... to announce it has signed a lease for a new ... Colorado. The 6,600 sq. ft. core facility at 2422 S. ... offices, administrative personnel, as well as the Lab Division core ...
Cached Medicine Technology:VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA® 2VIVUS Submits Briefing Document to FDA, Announces Follow-up Meeting to Discuss QNEXA® 3Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility 2Cannabis Science Signs Lease for New 6,600 sq. ft. Corporate Headquarters and Laboratory Facility 3
...
...
Rhoton Curettes, titanium, length 191 mm, straight....
Sundt Slim-Line Temporary Vessel Clips used for temporary vascular occlusion during intracranial surgical procedures. Non-magnetic, MP35N, MRI compatible, gold color. Bayonet....
Medicine Products: